← All market news

REPL News

Recent headlines mentioning REPL, newest first.

• REPL neutral

  Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

  manilatimes.net·Jul 30, 2026·Advisory Committee voted 10 to 3 that the efficacy results from the IGNYTE study are evaluable and clinically meaningful WOBURN, Mass., July 30, 2026 (GLOBE NE...